Phase IV, Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Patients Undergoing Procedure-Type Sedation

Phase IV, Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Patients Undergoing Procedure-Type Sedation

Dexmedetomidine (Precedex™) may be used as an alternative sedative in children, maintaining spontaneous breathing, and avoiding tracheal intubation in a non-intubated moderate or deep sedation (NI-MDS) approach. This open-label, single-arm, multicenter study evaluated the safety of dexmedetomidine i...

Full description

Bibliographic Details
Main Authors: Edmund H. Jooste, Gregory B. Hammer, Christian R. Reyes, Vaibhav Katkade, Peter Szmuk
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Pharmacology
Subjects:
alpha2 agonist
dexmedetomidine
non-intubated
pediatric
sedation
NCT01519167; https://clinicaltrials.gov/ct2/show/NCT01519167
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00529/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00529/full

Similar Items